Your browser doesn't support javascript.
loading
Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study.
Younger, E; Jones, R L; den Hollander, D; Soomers, V L M N; Desar, I M E; Benson, C; Young, R J; Oosten, A W; de Haan, J J; Miah, A; Zaidi, S; Gelderblom, H; Steeghs, N; Husson, O; van der Graaf, W T A.
Afiliação
  • Younger E; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Division of Clinical Studies, Institute of Cancer Research, London, UK.
  • den Hollander D; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Soomers VLMN; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Desar IME; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Benson C; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Young RJ; Academic Unit of Clinical Oncology, The University of Sheffield, Sheffield, UK.
  • Oosten AW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • de Haan JJ; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
  • Miah A; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Division of Clinical Studies, Institute of Cancer Research, London, UK.
  • Zaidi S; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK.
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Husson O; Division of Clinical Studies, Institute of Cancer Research, London, UK; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: olga.husson@icr.ac.uk.
  • van der Graaf WTA; Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, UK; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
ESMO Open ; 6(5): 100258, 2021 10.
Article em En | MEDLINE | ID: mdl-34509803
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article